JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

Inicio・Lista de Acciones・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Cerrado

1.91 -2.55

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.8900000000000001

Máximo

Métricas clave
By Trading Economics
Ingresos	6.9M -9.4M
Ventas	12M 63M
Margen de beneficios	-15.026
Empleados	450
EBITDA	7M -5.2M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+106.06% upside

Dividendos
By Dow Jones
Próximas Ganancias	8 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-448K 128M
Apertura anterior	4.46
Cierre anterior	1.91

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

7.16 / 7.65 Soporte y Resistencia

Treace Medical Concepts Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 abr 2026, 23:15 UTC

Noticias de Eventos Importantes

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 abr 2026, 23:08 UTC

Ganancias

Principales Movimientos del Mercado

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 abr 2026, 23:58 UTC

Ganancias

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 abr 2026, 23:58 UTC

Ganancias

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 abr 2026, 23:56 UTC

Ganancias

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 abr 2026, 23:56 UTC

Ganancias

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 abr 2026, 23:48 UTC

Charlas de Mercado

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 abr 2026, 23:42 UTC

Charlas de Mercado

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 abr 2026, 23:34 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 abr 2026, 23:30 UTC

Charlas de Mercado

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 abr 2026, 23:08 UTC

Charlas de Mercado

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 abr 2026, 23:02 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 abr 2026, 23:02 UTC

Charlas de Mercado

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 abr 2026, 22:42 UTC

Charlas de Mercado

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 abr 2026, 22:10 UTC

Ganancias

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 abr 2026, 22:09 UTC

Ganancias

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 abr 2026, 22:09 UTC

Ganancias

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 abr 2026, 22:09 UTC

Ganancias

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 abr 2026, 21:56 UTC

Ganancias

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 abr 2026, 21:55 UTC

Ganancias

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 abr 2026, 21:55 UTC

Ganancias

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 abr 2026, 21:44 UTC

Ganancias

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 abr 2026, 21:43 UTC

Ganancias

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 abr 2026, 21:41 UTC

Ganancias

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 abr 2026, 21:41 UTC

Ganancias

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 abr 2026, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

27 abr 2026, 20:50 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

27 abr 2026, 20:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

27 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

27 abr 2026, 20:39 UTC

Ganancias

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparación entre iguales

Cambio de precio

Treace Medical Concepts Inc previsión

Precio Objetivo

By TipRanks

106.06% repunte

Estimación a 12 Meses

Media 4.08 USD 106.06%

Máximo 7 USD

Mínimo 2.25 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Treace Medical Concepts Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Treace Medical Concepts Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

7.16 / 7.65Soporte y Resistencia

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.